ATE306940T1 - Zusammensetzung gegen coccidiose - Google Patents

Zusammensetzung gegen coccidiose

Info

Publication number
ATE306940T1
ATE306940T1 AT00850205T AT00850205T ATE306940T1 AT E306940 T1 ATE306940 T1 AT E306940T1 AT 00850205 T AT00850205 T AT 00850205T AT 00850205 T AT00850205 T AT 00850205T AT E306940 T1 ATE306940 T1 AT E306940T1
Authority
AT
Austria
Prior art keywords
composition
composition against
against coccidiosis
coccidiosis
medicament
Prior art date
Application number
AT00850205T
Other languages
English (en)
Inventor
Shoaa Abdul-Rahman
Original Assignee
New Pharma Res Sweden Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Pharma Res Sweden Ab filed Critical New Pharma Res Sweden Ab
Application granted granted Critical
Publication of ATE306940T1 publication Critical patent/ATE306940T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
AT00850205T 2000-12-04 2000-12-04 Zusammensetzung gegen coccidiose ATE306940T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00850205A EP1210950B1 (de) 2000-12-04 2000-12-04 Zusammensetzung gegen Coccidiose

Publications (1)

Publication Number Publication Date
ATE306940T1 true ATE306940T1 (de) 2005-11-15

Family

ID=8175689

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00850205T ATE306940T1 (de) 2000-12-04 2000-12-04 Zusammensetzung gegen coccidiose

Country Status (6)

Country Link
EP (1) EP1210950B1 (de)
CN (1) CN1210064C (de)
AT (1) ATE306940T1 (de)
AU (1) AU2002224308A1 (de)
DE (1) DE60023321D1 (de)
WO (1) WO2002045751A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8299037B2 (en) 2007-04-19 2012-10-30 Poulpharm B.V.B.A. Feed or pharmaceutical composition comprising apramycin or an adequate salt thereof
CN103018440B (zh) * 2012-11-23 2015-09-16 河南科技学院 一种氯羟吡啶胶体金层析检测试纸条或卡

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1140315A (en) * 1966-07-27 1969-01-15 Pfizer & Co C Animal feeds
FR2605221B1 (fr) * 1986-10-20 1989-09-01 Sanofi Sa Compositions pharmaceutiques ou veterinaires contenant de la de(hydroxymethyl)-25 deoxy-25 oxo-25 monensine
EP0642797B1 (de) * 1993-09-09 2000-05-17 Takeda Chemical Industries, Ltd. Formulierung enthaltend einen antibakteriellen und einen Antiulcus Wirkstoff
US6132768A (en) * 1995-07-05 2000-10-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors

Also Published As

Publication number Publication date
AU2002224308A1 (en) 2002-06-18
EP1210950B1 (de) 2005-10-19
EP1210950A1 (de) 2002-06-05
DE60023321D1 (de) 2006-03-02
WO2002045751A1 (en) 2002-06-13
CN1482920A (zh) 2004-03-17
CN1210064C (zh) 2005-07-13

Similar Documents

Publication Publication Date Title
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
HRP20040059B1 (hr) Tretman infekcije nokta s no
DE60236541D1 (de) Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
MXPA03011515A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
DK1458360T3 (da) Pulmonær afgivelse af aminoglycosider
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
SE0301886D0 (sv) New use V
EA200300929A1 (ru) Новые лекарственные композиции на основе антихолинергических средств и ингибиторов pde-iv
WO2006044362A3 (en) N-sulfonylpiperidine cannabinoid receptor 1 antagonists
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
BR0306922A (pt) N-pirazinil-fenilsulfonamidas e seu uso no tratamento de doenças mediadas por quimocina
WO2002102351A3 (en) Compositions comprising a cationic homopolymer and their use for stabilization of an oxidizing solution
PL1620425T3 (pl) Podstawione 3-cyjanotiofenoacetamidy jako antagoniści receptora glukagonu
EA200601837A1 (ru) Бензоксазины для лечения заболеваний дыхательных путей
SE0102055D0 (sv) New Compounds
DE60233350D1 (de) IMIDAZOi2,1-B -1,3,4-THIADIAZOLE SULFONAMIDES
EE05124B1 (et) Toimeainena dotsetakseeli v?i selle hdraati sisaldava kompositsiooni kasutamine
ATE554753T1 (de) 2,2'-dithio-bis(ethansulfonat) für den einsatz zur hemmung paclitaxel-induzierter abnormer thermoesthesia
MX2007001953A (es) Enantiomeros de pirimidonas fusionadas seleccionadas y usos en el tratamiento y prevencion del cancer.
SE0004101D0 (sv) New use
PT1799696E (pt) Fosfoindoles como inibidores de hiv
SE0000303D0 (sv) Novel compounds
DE60023321D1 (de) Zusammensetzung gegen Coccidiose
SE0102641D0 (sv) Novel compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties